The Epipen delivers a dose of epinephrine, otherwise known as adrenaline, to treat extreme allergic reactions. It’s been around for more than a century. And the pen that delivers the medication has been around since the 1970s, when it was first developed by the US military with taxpayer dollars.
Epinephrine was invented in Japan. This jump-started other areas of emergency medication for heart and lung problems. The hormone is now used in hospitals around the world, and is included on the WHO’s list of essential medicine. It only costs a few dollars for a vial.
Mylan, which is the corporation with the legal right to the taxpayer funded Epipen, recently relocated outside the United States to avoid paying taxes.
Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch’s total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.
Mylan was able to rip off the public because it bought legislation through corrupt politicians, and let’s face it, the US government from the White House to almost every US senator and almost every US member of the House of Representatives have been bought and packaged by big business so as to increase their profits at the expense of the 99 percent.
According to NBC News, “After Mylan acquired EpiPen the company also amped up its lobbying efforts. In 2008, its reported spending on lobbying went from $270,000 to $1.2 million, according to opensecrets.org.
Legislation that enhanced its bottom line followed, with the FDA changing its recommendations in 2010 that two EpiPens be sold in a package instead of one and that they be prescribed for at-risk patients, not just those with confirmed allergies. And in 2013 the government passed a law to give block grants to states that required they be stocked in public schools.
In 2007 the company bought the rights to EpiPen, a device used to provide emergency epinephrine to stop a potentially fatal allergic reaction and began raising its price. In 2008 and 2009, Mylan raised the price by 5 percent. At the end of 2009 it tried out a 19 percent hike. The years 2010-2013 saw a succession of 10 percent price hikes.
The stock price more than tripled, going from $13.29 in 2007 to a high of $47.59 in 2016.”
In other words, the US government aided and abetted a monopoly so that it could redistribute income from the 99 to the 1 percent. Furthermore, as a complete monopoly, the US government allowed Mylan to rip off the needy in violation of the numerous US laws, which include the Sherman Anti-Trust Act.
That’s how corrupt your government is.